Blueprint Neurotherapeutic Network (BPN), preclinical neurotherapeutic small molecule development
Dr. Hachicha joined the Division of Translational Research (DTR), NINDS/NIH, in May 2016 as a Scientific Project Manager for CNS-related drug development activities and currently directs the HEAL NIH Pain Therapeutics Development Program (PTDP) as a Program Director, which comprises a series of drug discovery and development programs spanning hit-to-lead through Phase I clinical studies across small molecules, antibodies, ASOs, and gene therapy modalities. Dr. Hachicha received his Ph.D. in Immunology from Laval University, Canada, and conducted his postdoctoral research at Brigham and Women’s Hospital, Harvard Medical School. He brings over 20 years of experience advancing therapeutic programs from target identification through Phase I clinical translation across CNS disorders, chronic pain, neuroinflammation, and autoimmune/inflammatory diseases. Dr. Hachicha demonstrates excellent interpersonal skills and operates at the intersection of deep scientific expertise and operational rigor, directing complex, multimodality research portfolios, building academic–industry partnerships, driving commercialization milestones, and leading cross-functional teams to deliver translational goals with speed, clarity, and accountability.